Walter FRIES

Professore Ordinario di gastroenterologia

Università degli Studi di Palermo

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Walter FRIES is a Professore Ordinario di gastroenterologia at Università degli Studi di Messina, Italy. His research areas focus on inflammatory bowel disease, particularly cardiovascular risk assessments, the effectiveness of various treatments like tofacitinib, and the management of conditions associated with chronic diarrhea. He has contributed significantly to the understanding of the psychological impacts of these diseases and the appropriate care strategies for elderly patients.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (15)

Giuseppe Mandraffino

Senior Assistant Professor

University of Messina

ITALY

Walter FRIES

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Cardiovascular Risk Assessments and Ultrasound-Assisted Re-Stratification in Patients with Inflammatory Bowel Disease (IBD)

Comparative effectiveness and safety of tofacitinib and filgotinib in patients with ulcerative colitis: A propensity score-weighted cohort study

Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC)

The Effectiveness of Risankizumab as Induction Therapy for Crohn’s Disease: Data From the Sicilian Network for Inflammatory Bowel Diseases

Bile acid diarrhea in patients with chronic diarrhea. Current appraisal and recommendations for clinical practice

Psychological impairment in inflammatory bowel diseases: the key role of coping and defense mechanisms

Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD)

Epidemiology and Clinical Course of late onset Inflammatory Bowel Disease

Efficacy and Safety of Biological Therapies and JAK Inhibitors in Older Patients with Inflammatory Bowel Disease

Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs?

Mitigating the risk of Tofacitinib-induced adverse events in the elderly population with Ulcerative Colitis

Low Adherence is Associated with Chronic Active Disease in Ulcerative Colitis: A Retrospective Study from a Single Referral Center

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project

Ulcerative Colitis in Adulthood and in Older Patients: Same Disease, Same Outcome, Same Risks?

Ménétrier’s disease in a patient with refractory ulcerative colitis: a clinical challenge and review of the literature

A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease

A real world investigation on prevalence, clinical features, and therapy of inflammatory bowel disease in the city of messina, italy

Collaborators (15)

Giuseppe Mandraffino

Jakob Seidelin

Gregory Thomas Charles Moore

Peter Schwarz

Marco Ventimiglia

Federica Bellone

Samuel Huber

ALBERTO SARDELLA

Antonino Catalano

carolina ciacci

Bu'Hussain Hayee

Orlando Silvestro

Edoardo Spina

Farhad Peerani

Edoardo Savarino

Make your next move.